RxDoctor Payments Data

Rajen Desai

Psychiatry · Beaumont, TXNPI 1992701940

Payments from drug & device makers

$3,961in general payments, 2019–2025

Across 170 payments — averaging $23.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$1K
  • Teva Pharmaceuticals USA, Inc.$539
  • Takeda Pharmaceuticals U.S.A., Inc.$461
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$391
  • Neurocrine Biosciences, Inc.$328
  • Otsuka America Pharmaceutical, Inc.$183
  • plus $814 from 9 others

What the payments were for

  • Food & beverage$3,90799%
  • Education$541%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,961 in reported general payments places this provider in the 80th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine28$1,510
Ziprasidone Hcl12$503
Doxepin Hcl12$349
Alprazolam54$187
Divalproex Sodium ErDivalproex Sodium12$177
Lorazepam19$176
Zolpidem Tartrate22$119
Escitalopram Oxalate11$45

Paid to pharmacies, not to this prescriber.

Other psychiatry in Beaumont

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →